Lyka Labs Limited

Web: lykalabs.com NSE: LYKALABS BSE: 500259 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

60 2(-3%)

Volume

20k as on 30, Jan

Open

High

Low

VWAP

52 Week High

129

52 Week Low

Viand Research Rating

Quality Score

00/00

Growth Score

00/00

Valuation Score

00/00

Momentum Score

00/00

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

214

No. of Shares

3.57

P/E

140.62

P/B

5.62

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

3.99

ROCE

Profit Growth

Listing Date

08-Feb-95

Promoter Holding

58.16%

FII Holding

0.29%

DII Holding

0.66%

Price Chart

Price Performance

1 Week2%

1 Month6%

3 Months24%

6 Months37%

1 Year52%

YTD7%

Moving Average

5 Day SMA73

10 Day SMA74

20 Day SMA77

30 Day SMA76

50 Day SMA78

61 Day SMA80

80 Day SMA84

200 Day SMA99

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	77	74	76	77
Resistance 2	76	74	75	76
Resistance 1	75	74	75	75
Pivot Point	74	73	74	74
Support 1	73	73	73	73
Support 2	72	73	73	72
Support 3	71	73	72	71

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	Div Yld %
1	SUNPHARMA	4,40,891	1838	2%	14%	2%	9%	39	0	0	0
2	DIVISLAB	1,79,072	6746	2%	6%	4%	1%	65	0	0	0
3	TORNTPHARM	1,50,046	4434	0%	8%	18%	40%	64	0	0	0
4	APOLLOHOSP	1,19,154	8287	3%	7%	12%	17%	58	0	0	0
5	CIPLA	1,14,271	1415	1%	10%	7%	4%	22	0	0	0
6	ZYDUSLIFE	1,10,635	1099	6%	16%	15%	17%	20	0	0	0
7	DRREDDY	1,09,696	1314	0%	1%	7%	7%	20	0	0	0
8	LUPIN	1,04,085	2276	1%	2%	9%	15%	23	0	0	0
9	MANKIND	99,891	2419	3%	7%	7%	2%	49	0	0	0
10	MAXHEALTH	95,023	976	7%	1%	15%	14%	0	0	0	0
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 58.16%	(0.01) 58.16%	(0.01) 58.16%	(0.01) 58.16%	(0.01) 58.16%	(0.01) 58.11%	(0.01) 58.11%	(3.31) 58.11%	(0.01) 54.81%	(0.01) 54.81%	(0.21) 54.81%	(3.61) 54.58%	(3.41) 51.00%	(0.01) 47.58%	(-0.21) 47.58%	(0.01) 47.80%	(27.81) 47.79%	(0.01) 20.04%	(0.01) 20.00%
FIIs	(0.11) 0.29%	(0.01) 0.17%	(0.01) 0.17%	(-0.11) 0.16%	(0.11) 0.24%	(0.01) 0.15%	(0.01) 0.15%	(0.01) 0.15%	(0.01) 0.17%	(0.01) 0.17%	(0.01) 0.18%	(0.01) 0.17%	(-0.21) 0.18%	(-0.21) 0.37%	(-0.21) 0.57%	(-0.41) 0.76%	(0.01) 1.12%	(-0.91) 1.13%	(0.01) 2.07%
DIIs	(0.01) 0.66%	(0.01) 0.66%	(0.01) 0.66%	(0.01) 0.66%	(0.01) 0.66%	(0.01) 0.66%	(-0.11) 0.66%	(-0.11) 0.75%	(0.21) 0.81%	(0.21) 0.62%	(0.01) 0.41%	(-3.31) 0.41%	(-0.31) 3.74%	(0.01) 4.00%	(0.01) 4.00%	(2.81) 3.99%	(0.71) 1.19%	(-1.41) 0.47%	(0.01) 1.85%
Public	40.89%	40.99%	40.99%	41.02%	40.93%	41.07%	41.08%	40.99%	44.21%	44.41%	44.61%	44.84%	45.08%	48.05%	47.85%	47.45%	49.89%	78.36%	76.08%
No. of Shareholders	26,727	27,155	27,743	28,189	28,472	29,099	28,943	25,716	25,717	26,422	26,652	27,202	26,820	28,515	28,433	26,969	26,220	27,720	20,672

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	28.03	30.73	36.66	33.03	33.43	33.8	41.16	30.11	27.77	32.56	27.99	22.88	22.24	17.82	25.53	27.49	35.19	35.57	73.89	49.44
Expenses	34.48	29.08	39.2	29.35	29.35	28.61	36.21	26.4	25.75	25.69	23.82	20.24	18.94	15.61	20.5	21.18	22.59	22.55	28.27	19.54
Operating Profit	-6.45	1.65	-2.54	3.68	4.08	5.19	4.95	3.71	2.02	6.87	4.17	2.64	3.3	2.21	5.03	6.31	12.6	13.02	45.62	29.9
OPM %	-23.01	5.37	-6.93	11.14	12.2	15.36	12.03	12.32	7.27	21.1	14.9	11.54	14.84	12.4	19.7	22.95	35.81	36.6	61.74	60.48
Other Income	0.61	1.16	1.09	0.63	0.82	0.83	0.03	0.56	0.32	0.54	-0.18	0.38	0.02	-5.95	0.98	0.95	-2.27	0.58	-3.2	0.47
Interest	0.7	0.82	0.79	0.85	0.47	0.61	0.54	0.65	1.07	1.28	1.19	1.35	2.85	3.08	3.03	2.91	2.99	4.64	5.57	6.93
Depreciation	2.04	2.15	2.15	2.11	1.42	1.83	1.76	1.76	2.9	2.84	3.59	3.47	3.47	3.47	3.62	3.59	9.46	2.24	3.52	2.13
Profit before tax	-8.58	-0.16	-4.39	1.35	3.01	3.58	2.68	1.86	-1.63	3.29	-0.79	-1.8	-3	-10.29	-0.64	0.76	-2.12	6.72	33.33	21.31
Tax %	-6.06	-6.25	-26.65	26.67	32.89	24.3	28.36	30.65	28.22	38.6	-22.78	7.22	0	2.24	-46.88	6.58	607.08	6.55	16.98	8.59
Net Profit	-8.07	-0.15	-3.22	0.99	2.03	2.7	1.91	1.29	-2.09	1.78	-0.49	-1.85	-3.01	-10.42	-0.38	0.6	-15.07	6.09	28.43	19.55
EPS in Rs	-2.13	0	-0.94	0.26	0.5	0.76	0.59	0.4	-0.63	0.54	-0.15	-0.56	-0.98	-3.63	-0.13	0.21	-5.25	2.12	9.91	6.81

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Jun 2015	Jun 2014	Mar 2013	Jan 1900
Sales	128	138	111	93	194	86	61	71	60	110	130	166	119	127	130
Expenses	132	121	95	76	93	67	65	73	63	87	110	139	111	99	110
Operating Profit	-4	18	16	17	101	20	-4	-2	-4	23	20	28	8	28	20
OPM %	-3	13	14	18	52	23	-6	-3	-6	21	16	17	7	22	16
Other Income	4	2	1	-4	-4	0	-30	1	4	-2	8	4	25	3	8
Interest	3	2	5	12	20	26	20	7	10	19	15	24	27	19	15
Depreciation	8	7	13	14	17	8	8	7	11	10	9	11	9	12	9
Profit before tax	-12	11	-1	-13	59	-14	-62	-15	-20	-8	4	-3	-3	0	4
Tax %	-11	29	182	0	35	-29	1	-59	-5	-19	-5	31	45	0	-5
Net Profit	-10	8	-3	-13	38	-10	-63	-6	-19	-7	4	-5	-5	-1	4
EPS in Rs	-2.81	2.24	-0.75	-4.3	13.59	-4.03	-21.1	-1.97	-6.14	-2.51	1.67	-2.29	-3.05	-0.33	1.67
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Jun 2015	Jun 2014	Mar 2013
Cash from Operating Activity	5	2	2	9	79	9	5	27	11	31	12	27	89	11
Cash from Investing Activity	-9	-12	-9	7	-6	0	0	-4	-3	-13	17	37	-57	5
Cash from Financing Activity	4	5	2	-22	-63	-12	3	-23	-10	-19	-30	-60	-26	-13
Net Cash Flow	0	-5	-6	-5	10	-3	9	-1	-3	0	-1	4	6	3

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Jun 2015	Jun 2014	Mar 2013
Equity Capital	36	36	36	36	33	31	29	29	29	28	28	22	22	22	22	22
Reserves	57	65	68	63	35	15	-15	-54	-43	15	21	16	22	20	30	44
Borrowings	49	32	39	35	59	75	130	163	141	96	113	126	121	137	164	127
Other Liabilities	33	35	33	34	30	31	42	52	73	76	67	88	77	100	113	96
Total Liabilities	175	168	176	168	157	152	186	190	200	216	229	252	242	279	329	289
Fixed Assets	87	87	85	58	58	68	94	98	105	108	116	133	104	122	162	93
CWIP	2	1	1	28	23	16	18	26	28	31	28	24	30	27	22	47
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6
Other Assets	86	80	90	83	76	67	74	66	68	77	85	94	107	130	145	143
Total Assets	175	168	176	168	157	152	186	190	200	216	229	252	242	279	329	289

Delivery

#	Date	44 45% 64	Value (Cr)	Q/T 133	Del 63	Del 1
1	29-May	58	0	111	81	0
2	27-May	58	0	79	62	0
3	26-May	60	1	84	73	1
4	25-May	62	0	63	65	0
5	22-May	61	0	55	72	0
6	21-May	61	0	23	80	0
7	20-May	61	0	135	50	0
8	19-May	60	0	77	80	0
9	16-Apr	58	0	65	57	0
10	15-Apr	57	1	71	55	0
11	13-Apr	57	0	75	57	0
12	10-Apr	58	0	71	55	0
13	9-Apr	58	0	60	67	0
14	8-Apr	59	1	48	48	0
15	7-Apr	59	1	60	44	0
16	6-Apr	54	0	33	42	0
17	2-Apr	56	0	45	50	0
18	1-Apr	51	0	66	49	0
19	30-Mar	45	0	49	47	0
20	27-Mar	46	1	55	52	0
21	25-Mar	51	1	66	54	0
22	24-Mar	49	1	242	84	1
23	23-Mar	50	2	162	82	1
24	20-Mar	55	1	71	62	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
18-May	214c	7c	3.14
15-May	221c	4c	1.71
14-May	217c	3c	1.32
13-May	214c	5c	2.39
12-May	219c	16c	8.07
15-Apr	203c	0	0

Stock Checklist

Price is below from 52 week high low average: 63%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView